BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14667284)

  • 1. The rise and fall of PC-SPES: new generation of herbal supplement, adulterated product, or new drug?
    Blumenthal M
    Integr Cancer Ther; 2002 Sep; 1(3):266-70. PubMed ID: 14667284
    [No Abstract]   [Full Text] [Related]  

  • 2. PC-SPES: a brief overview.
    Cordell GA
    Integr Cancer Ther; 2002 Sep; 1(3):271-86. PubMed ID: 14667285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PC-SPES: hope or hype?
    Kosty MP
    J Clin Oncol; 2004 Sep; 22(18):3657-9. PubMed ID: 15289490
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
    Oh WK; Kantoff PW; Weinberg V; Jones G; Rini BI; Derynck MK; Bok R; Smith MR; Bubley GJ; Rosen RT; DiPaola RS; Small EJ
    J Clin Oncol; 2004 Sep; 22(18):3705-12. PubMed ID: 15289492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PC-SPES--a lesson for future dietary supplement research.
    White J
    J Natl Cancer Inst; 2002 Sep; 94(17):1261-3. PubMed ID: 12208885
    [No Abstract]   [Full Text] [Related]  

  • 6. PC-SPES.
    Ko R; Wilson RD; Loscutoff S
    Urology; 2003 Jun; 61(6):1292. PubMed ID: 12809931
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alternative means of drug therapy of cancer: PC-SPES -- anticancer properties and mechanisms of action].
    Korman DB
    Vopr Onkol; 2013; 59(5):539-47. PubMed ID: 24260878
    [No Abstract]   [Full Text] [Related]  

  • 8. PC-SPES: A cautionary tale.
    Harv Mens Health Watch; 2002 Dec; 7(5):8. PubMed ID: 12499133
    [No Abstract]   [Full Text] [Related]  

  • 9. PC-SPES.
    Nagourney RA
    J Med Food; 2002; 5(3):107-8. PubMed ID: 12495582
    [No Abstract]   [Full Text] [Related]  

  • 10. Contamination of PC-SPES remains a mystery.
    Reynolds T
    J Natl Cancer Inst; 2002 Sep; 94(17):1266-8. PubMed ID: 12208887
    [No Abstract]   [Full Text] [Related]  

  • 11. PC Spes.
    Med Lett Drugs Ther; 2001 Feb; 43(1098):15-6. PubMed ID: 11182805
    [No Abstract]   [Full Text] [Related]  

  • 12. PC-SPES: a herbal therapy for the treatment of hormone refractory prostate cancer.
    Meyer JP; Gillatt DA
    Prostate Cancer Prostatic Dis; 2002; 5(1):13-5. PubMed ID: 15195124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in research on PC-SPES anti-cancer agents in prostatic carcinoma in USA].
    Zhang QH; Chen KJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Apr; 21(4):295-9. PubMed ID: 12577362
    [No Abstract]   [Full Text] [Related]  

  • 14. [PC-SPES and ProstaSol: Chinese herbal medicine as a treatment for prostate cancer].
    Jensen JB; Langkilde NC
    Ugeskr Laeger; 2004 Dec; 166(50):4611-2. PubMed ID: 15633553
    [No Abstract]   [Full Text] [Related]  

  • 15. Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES.
    Meade-Tollin LC; Wijeratne EM; Cooper D; Guild M; Jon E; Fritz A; Zhou GX; Whitesell L; Liang JY; Gunatilaka AA
    J Nat Prod; 2004 Jan; 67(1):2-4. PubMed ID: 14738375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine patients are talking about: PC-SPES.
    Lee CO
    Clin J Oncol Nurs; 2005 Feb; 9(1):113-4. PubMed ID: 15751507
    [No Abstract]   [Full Text] [Related]  

  • 17. PC-SPES withdrawal response.
    Chaudhary UB; Rashid M; Keane TE
    Acta Oncol; 2004; 43(8):772-3. PubMed ID: 15764226
    [No Abstract]   [Full Text] [Related]  

  • 18. PC-SPES in prostate cancer.
    Small EJ
    N Engl J Med; 1999 Feb; 340(7):566-7; author reply 567-8. PubMed ID: 10026050
    [No Abstract]   [Full Text] [Related]  

  • 19. PC-SPES in prostate cancer.
    Geliebter J; Tiwari R; Wu JM
    N Engl J Med; 1999 Feb; 340(7):567-8. PubMed ID: 10026051
    [No Abstract]   [Full Text] [Related]  

  • 20. Herbal supplement PC-Spes for prostate cancer.
    de Lemos ML
    Ann Pharmacother; 2002 May; 36(5):921-6. PubMed ID: 11978173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.